The triple A (AAA) model globally recapitulates adverse outcomes in essential thrombocythemia

Blood Cancer J. 2024 Oct 1;14(1):169. doi: 10.1038/s41408-024-01151-2.

Authors

Luca Tosoni¹, Gian Luca Morelli¹, Gaia Tomadini¹, Davide Lazzarotto¹, Carla Filì¹, Erica Simeone¹, Maria Elena Zannier¹, Chiara Callegari¹, Matteo Fanin¹, Giulia Battaglia¹, Melissa Bergnach¹, Daniela Damiani^{1

2}, Renato Fanin^{1

2}, Mario Tiribelli^{3

4}

Affiliations

¹ Division of Hematology and Bone Marrow Transplant, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
² Department of Medicine, University of Udine, Udine, Italy.
³ Division of Hematology and Bone Marrow Transplant, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy. [email protected].
⁴ Department of Medicine, University of Udine, Udine, Italy. [email protected].

No abstract available

Publication types

Letter

MeSH terms

Aged
Female
Humans
Janus Kinase 2 / genetics
Male
Middle Aged
Prognosis
Thrombocythemia, Essential* / genetics

Substances

Janus Kinase 2